Disulfiram Inhibits Epithelial–Mesenchymal Transition Through TGFβ–ERK–Snail Pathway Independently of Smad4 to Decrease Oral Squamous Cell Carcinoma Metastasis [Corrigendum]
Bu W, Wang Z, Meng L, et al. Cancer Manag Res. 2019;11:3887– 3898. The authors have advised due to an error at the time of figure assembly, Figures 2 and 3 on pages 3892 and 3893, respectively are incorrect. The correct Figures are shown in Download Article. The authors apologize for this...
Guardado en:
Autores principales: | Bu W, Wang Z, Meng L, Li X, Liu X, Chen Y, Xin Y, Li B, Sun H |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/411fd999efb643139a841bcae61126a3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Neuropatía por disulfiram: Comunicación de tres casos clínicos
por: Bevilacqua,Jorge A, et al.
Publicado: (2002) -
Gold nanoparticles attenuate metastasis by tumor vasculature normalization and epithelial–mesenchymal transition inhibition
por: Li W, et al.
Publicado: (2017) -
Circulating Tumor Cells in Esophageal Squamous Cell Carcinoma – Mini Review
por: Shi Y, et al.
Publicado: (2021) -
TGF-β-Induced TMEPAI Promotes Epithelial–Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration
por: Wardhani BWK, et al.
Publicado: (2021) -
GPR37 promotes the malignancy of lung adenocarcinoma via TGF-β/Smad pathway
por: Wang Jian, et al.
Publicado: (2020)